High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened merkel cell polyomavirus large T antigens

Journal of Virology

Volumn 88, Issue 6, 2014, Pages 3144-3160

  Borchert, Sophie ^a,b   Czech Sioli, Manja ^a   Neumann, Friederike ^a   Schmidt, Claudia ^a   Wimmer, Peter ^b   Dobner, Thomas ^b   Grundhoff, Adam ^b   Fischer, Nicole ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL LINE; VIRUS REPLICATION;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, VIRAL, TUMOR; CARCINOMA, MERKEL CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; DOWN-REGULATION; HUMANS; KINETICS; MERKEL CELL POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 84894543613     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02916-13     Document Type: Article

References (72)

1. DeCaprio JA, Garcea RL. 2013. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 11:264-276. http://dx.doi.org/10.1038/nrmicro2992.
2. Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B. 2013. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS One 8:e58021. http://dx.doi.org/10.1371/journal.pone.0058021.
3. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100. http://dx.doi.org/10.1126/science.1152586.
4. Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D. 2009. MCpolyomavirus is frequently present in Merkel cell carcinoma of European patients. J. Invest. Dermatol. 129:248-250. http://dx.doi.org/10.1038/jid.2008.198.
5. Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y. 2009. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am. J. Surg. Pathol. 33:1378-1385. http://dx.doi.org/10.1097/PAS.0b013e3181aa30a5.
6. Foulongne V, Kluger N, Dereure O, Brieu N, Guillot B, Segondy M. 2008. Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg. Infect. Dis. 14:1491-1493. http://dx.doi.org/10.3201/eid1409.080651.
7. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. 2009. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J. Invest. Dermatol. 129:246-248. http://dx.doi.org/10.1038/jid.2008.229.
8. Kassem A, Schopflin A, Diaz C, Weyers W, Stickeler E, Werner M, Zur Hausen A. 2008. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 68:5009-5013. http://dx.doi.org/10.1158/0008-5472.CAN-08-0949.
9. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. U.S.A. 105:16272-16277. http://dx.doi.org/10.1073/pnas.0806526105.
10. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y. 2009. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer 125:1243-1249. http://dx.doi.org/10.1002/ijc.24510.
11. Cherington V, Morgan B, Spiegelman BM, Roberts TM. 1986. Recombinant retroviruses that transduce individual polyoma tumor antigens: effects on growth and differentiation. Proc. Natl. Acad. Sci. U.S.A. 83: 4307-4311. http://dx.doi.org/10.1073/pnas.83.12.4307.
12. Kornbluth S, Cross FR, Harbison M, Hanafusa H. 1986. Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector. Mol. Cell. Biol. 6:1545-1551.
13. Pipas JM. 2009. SV40: cell transformation and tumorigenesis. Virology 384:294-303. http://dx.doi.org/10.1016/j.virol.2008.11.024.
14. Sullivan CS, Pipas JM. 2002. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66:179-202. http://dx.doi.org/10.1128/MMBR.66.2.179-202.2002.
15. Bollag B, Chuke WF, Frisque RJ. 1989. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J. Virol. 63:863-872.
16. Bollag B, Prins C, Snyder EL, Frisque RJ. 2000. Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 274:165-178. http://dx.doi.org/10.1006/viro.2000.0451.
17. Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, Vandyke T, Harlow E. 1990. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol. 64:1353-1356.
18. Fischer N, Brandner J, Fuchs F, Moll I, Grundhoff A. 2010. Detection of Merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: cell morphology and growth phenotype do not reflect presence of the virus. Int. J. Cancer 126:2133-2142. http://dx.doi.org/10.1002/ijc.24877.
19. Pantulu ND, Pallasch CP, Kurz AK, Kassem A, Frenzel L, Sodenkamp S, Kvasnicka HM, Wendtner CM, Zur Hausen A. 2010. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 116:5280-5284. http://dx.doi.org/10.1182/blood-2010-02-269829.
20. Arora R, Chang Y, Moore PS. 2012. MCV and Merkel cell carcinoma: a molecular success story. Curr. Opin. Virol. 2:489-498. http://dx.doi.org/10.1016/j.coviro.2012.05.007.
21. Cheng J, Rozenblatt-Rosen O, Paulson KG, Nghiem P, DeCaprio JA. 2013. Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities. J. Virol. 87:6118-6126. http://dx.doi.org/10.1128/JVI.00385-13.
22. Asselin C, Gelinas C, Bastin M. 1983. Role of the three polyoma virus early proteins in tumorigenesis. Mol. Cell. Biol. 3:1451-1459.
23. Asselin C, Vass-Marengo J, Bastin M. 1986. Mutation in the polyomavirus genome that activates the properties of large T associated with neoplastic transformation. J. Virol. 57:165-172.
24. Noda T, Satake M, Yamaguchi Y, Ito Y. 1987. Cooperation of middle and small T antigens of polyomavirus in transformation of established fibroblast and epithelial-like cell lines. J. Virol. 61:2253-2263.
25. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. 2011. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 121:3623-3634. http://dx.doi.org/10.1172/JCI46323.
26. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC. 2010. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 84: 7064-7072. http://dx.doi.org/10.1128/JVI.02400-09.
27. Kwun HJ, Shuda M, Feng H, Camacho CJ, Moore PS, Chang Y. 2013. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCF(Fbw7). Cell Host Microbe 14:125-135. http://dx.doi.org/10.1016/j.chom.2013.06.008.
28. Neumann F, Borchert S, Schmidt C, Reimer R, Hohenberg H, Fischer N, Grundhoff A. 2011. Replication, gene expression and particle production by a consensus Merkel cell polyomavirus (MCPyV) genome. PLoS One 6:e29112. http://dx.doi.org/10.1371/journal.pone.0029112.
29. Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J. 2013. Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J. Virol. 87:9173-9188. http://dx.doi.org/10.1128/JVI.01216-13.
30. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74. http://dx.doi.org/10.1099/0022-1317-36-1-59.
31. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD, et al. 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
32. Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59:221-226.
33. Brown TC, Cerutti PA. 1986. Ultraviolet radiation inactivates SV40 by disrupting at least four genetic functions. EMBO J. 5:197-203.
34. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N. 2010. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 399:23-30. http://dx.doi.org/10.1016/j.virol.2009.12.028.
35. Oswald F, Dobner T, Lipp M. 1996. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol. Cell. Biol. 16:1889-1895.
36. Nevels M, Tauber B, Spruss T, Wolf H, Dobner T. 2001. "Hit-and-run" transformation by adenovirus oncogenes. J. Virol. 75:3089-3094. http://dx.doi.org/10.1128/JVI.75.7.3089-3094.2001.
37. Härtl B, Zeller T, Blanchette P, Kremmer E, Dobner T. 2008. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 27:3673-3684. http://dx.doi.org/10.1038/sj.onc.1211039.
38. Wimmer P, Tauber B, Spruss T, Dobner T. 2010. Adenovirus type 5 early encoded proteins of the E1 and E4 regions induce oncogenic transformation of primary rabbit cells. J. Gen. Virol. 91:1828-1833. http://dx.doi.org/10.1099/vir.0.020537-0.
39. Wang X, Li J, Schowalter RM, Jiao J, Buck CB, You J. 2012. Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathog. 8:e1003021. http://dx.doi.org/10.1371/journal.ppat.1003021.
40. Schreiner S, Wimmer P, Groitl P, Chen SY, Blanchette P, Branton PE, Dobner T. 2011. Adenovirus type 5 early region 1B 55K oncoproteindependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells. J. Virol. 85:8752-8765. http://dx.doi.org/10.1128/JVI.00440-11.
41. Harlow E, Crawford LV, Pim DC, Williamson NM. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861-869.
42. Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T. 1997. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc. Natl. Acad. Sci. U.S.A. 94:1206-1211. http://dx.doi.org/10.1073/pnas.94.4.1206.
43. Hermannstädter A, Ziegler C, Kuhl M, Deppert W, Tolstonog GV. 2009. Wild-type p53 enhances efficiency of simian virus 40 large-Tantigen-induced cellular transformation. J. Virol. 83:10106-10118. http://dx.doi.org/10.1128/JVI.00174-09.
44. Banning C, Votteler J, Hoffmann D, Koppensteiner H, Warmer M, Reimer R, Kirchhoff F, Schubert U, Hauber J, Schindler M. 2010. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 5:e9344. http://dx.doi.org/10.1371/journal.pone.0009344.
45. Eward KL, Van Ert MN, Thornton M, Helmstetter CE. 2004. Cyclin mRNA stability does not vary during the cell cycle. Cell Cycle 3:1057-1061. http://dx.doi.org/10.4161/cc.3.8.987.
46. Stieler K, Fischer N. 2010. Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One 5:e11738. http://dx.doi.org/10.1371/journal.pone.0011738.
47. Leppard KN, Shenk T. 1989. The adenovirus E1B 55 kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8:2329-2336.
48. Liu X, Marmorstein R. 2007. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev. 21:2711-2716. http://dx.doi.org/10.1101/gad.1590607.
49. Jerabek-Willemsen M, Wienken CJ, Braun D, Baaske P, Duhr S. 2011. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 9:342-353. http://dx.doi.org/10.1089/adt.2011.0380.
50. Nakamura T, Sato Y, Watanabe D, Ito H, Shimonohara N, Tsuji T, Nakajima N, Suzuki Y, Matsuo K, Nakagawa H, Sata T, Katano H. 2010. Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma. Virology 398:273-279. http://dx.doi.org/10.1016/j.virol.2009.12.024.
51. Martin ME, Berk AJ. 1998. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 72:3146-3154.
52. Yew PR, Liu X, Berk AJ. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190-202. http://dx.doi.org/10.1101/gad.8.2.190.
53. Bargonetti J, Reynisdottir I, Friedman PN, Prives C. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898. http://dx.doi.org/10.1101/gad.6.10.1886.
54. Harris KF, Christensen JB, Imperiale MJ. 1996. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J. Virol. 70:2378-2386.
55. Jiang D, Srinivasan A, Lozano G, Robbins PD. 1993. SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8:2805-2812.
56. Peden KW, Srinivasan A, Farber JM, Pipas JM. 1989. Mutants with changes within or near a hydrophobic region of simian virus 40 large tumor antigen are defective for binding cellular protein p53. Virology 168:13-21. http://dx.doi.org/10.1016/0042-6822(89)90398-X.
57. Peden KW, Srinivasan A, Vartikar JV, Pipas JM. 1998. Effects of mutations within the SV40 large T antigen ATPase/p53 binding domain on viral replication and transformation. Virus Genes 16:153-165. http://dx.doi.org/10.1023/A:1007941622680.
58. Staib C, Pesch J, Gerwig R, Gerber JK, Brehm U, Stangl A, Grummt F. 1996. p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen. Virology 219:237-246. http://dx.doi.org/10.1006/viro.1996.0241.
59. Dilworth SM. 1990. Cell alterations induced by the large T-antigens of SV40 and polyoma virus. Semin. Cancer Biol. 1:407-414.
60. Imperiale MJ, Major EO. 2007. Polyomaviruses, p 2263-2298. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
61. Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. 2010. Proteinbinding assays in biological liquids using microscale thermophoresis. Nat. Commun. 1:100. http://dx.doi.org/10.1038/ncomms1093.
62. Kim HY, Ahn BY, Cho Y. 2001. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 20: 295-304. http://dx.doi.org/10.1093/emboj/20.1.295.
63. Tognon M, Corallini A, Martini F, Negrini M, Barbanti-Brodano G. 2003. Oncogenic transformation by BK virus and association with human tumors. Oncogene 22:5192-5200. http://dx.doi.org/10.1038/sj.onc.1206550.
64. Laude HC, Jonchere B, Maubec E, Carlotti A, Marinho E, Couturaud B, Peter M, Sastre-Garau X, Avril MF, Dupin N, Rozenberg F. 2010. Distinct Merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with Merkel cell carcinoma. PLoS Pathog. 6:e1001076. http://dx.doi.org/10.1371/journal.ppat.1001076.
65. Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N. 2009. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol. 218:48-56. http://dx.doi.org/10.1002/path.2532.
66. Liu X, Hein J, Richardson SC, Basse PH, Toptan T, Moore PS, Gjoerup OV, Chang Y. 2011. Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus. J. Biol. Chem. 286:17079-17090. http://dx.doi.org/10.1074/jbc.M110.192856.
67. Zhu J, Rice PW, Gorsch L, Abate M, Cole CN. 1992. Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 66:2780-2791.
68. Ahuja D, Saenz-Robles MT, Pipas JM. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745. http://dx.doi.org/10.1038/sj.onc.1209046.
69. Quartin RS, Cole CN, Pipas JM, Levine AJ. 1994. The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J. Virol. 68:1334-1341.
70. Rushton JJ, Jiang D, Srinivasan A, Pipas JM, Robbins PD. 1997. Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53. J. Virol. 71:5620-5623.
71. Pectasides D, Pectasides M, Economopoulos T. 2006. Merkel cell cancer of the skin. Ann. Oncol. 17:1489-1495. http://dx.doi.org/10.1093/annonc/mdl050.
72. Lilyestrom W, Klein MG, Zhang R, Joachimiak A, Chen XS. 2006. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20:2373-2382. http://dx.doi.org/10.1101/gad.1456306.